Point72 Hong Kong LTD Cytom X Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.6 - $9.0 $10,560 - $14,400	-1,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $7,990 - $9,756	1,235 Added 338.36%	1,600 $10,000
Q3 2020 Nov 16, 2020	BUY	$6.55 - $8.83 $2,390 - $3,222	365 New	365 $2,000
Q1 2020 May 15, 2020	SELL	$3.61 - $8.6 $4,097 - $9,761	-1,135 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $5,867 - $10,112	1,135 New	1,135 $9,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $17,093 - $25,067	-1,347 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $23,452 - $34,333	1,300 Added 2765.96%	1,347 $25,000
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $705 - $979	33 Added 235.71%	47 $1,000
Q1 2018 May 15, 2018	BUY	$21.76 - $34.22 $304 - $479	14 New	14 $0

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.